Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...

As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well. It had one of its worst effectiveness rates in more than a decade.

The CDC's interim VE analysis included data from 142,494 people in three surveillance networks. In outpatient settings, 26% to 32% of adults who tested positive for flu were vaccinated, compared with ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...

Moderna seeks to return to growth Its share price has lost 90% from pandemic peaks Anti-vaccine health secretary has disrupted US vaccine policy Feb 27 (Reuters) - Europe's medicines regulator ...

On Friday, Moderna’s mCombriax—a combined vaccine for both the flu and COVID—was recommended for authorization by European regulators, which opens the door for the vaccine’s approval in the European ...

The European Medicines Agency (EMA) has recommended granting marketing authorization to the combined influenza and COVID-19 messenger RNA (mRNA) vaccine, mCombriax (Moderna), for people aged 50 years ...

For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...

It’s unsurprising, but disappointing nonetheless: The president’s pick for surgeon general is a vaccine skeptic. During her Senate confirmation hearing Wednesday, Casey Means was caught in a bind ...

Neil Mabbott receives research funding from the UK Biotechnology and Biological Sciences Research Council, the Roslin Foundation, the Creutzfeldt-Jakob Disease Foundation, and Zoetis. Vaccines have ...

The company revised its plan to seek full approval for middle-aged adults and accelerated approval for seniors. (HealthDay News) — In a sudden reversal, the U.S. Food and Drug Administration (FDA) has ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...